acetyl-dl-leucine has been researched along with Vertigo in 5 studies
acetylleucine: used for treating vestibular-related imbalance and vertigo
Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)
Excerpt | Relevance | Reference |
---|---|---|
"To assess the efficacy of acetylleucine to improve or stop an attack of vertigo and dizziness (vertigo/dizziness)." | 9.01 | Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials. ( Blanchard, C; Boussageon, R; Jaafari, N; Naudet, F; Perault-Pochat, MC; Pouchain, D; Vaillant Roussel, H; Vanderkam, P, 2019) |
"For 40 years, the amino acid acetyl-DL-leucine (or isoleucine - Tanganil) has been used in clinical practice to reduce imbalance and autonomic manifestations associated with acute vertigo crises." | 5.14 | Effects of acetyl-DL-leucine in vestibular patients: a clinical study following neurotomy and labyrinthectomy. ( Dubreuil, C; Ferber-Viart, C; Vidal, PP, 2009) |
"To assess the efficacy of acetylleucine to improve or stop an attack of vertigo and dizziness (vertigo/dizziness)." | 5.01 | Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials. ( Blanchard, C; Boussageon, R; Jaafari, N; Naudet, F; Perault-Pochat, MC; Pouchain, D; Vaillant Roussel, H; Vanderkam, P, 2019) |
"For 40 years, the amino acid acetyl-DL-leucine (or isoleucine/Tanganil) has been used in clinical practice to reduce the imbalance and autonomic signs associated with acute vertigo crises." | 3.71 | In vitro effects of acetyl-DL-leucine (tanganil) on central vestibular neurons and vestibulo-ocular networks of the guinea-pig. ( Vibert, N; Vidal, PP, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vanderkam, P | 1 |
Blanchard, C | 1 |
Naudet, F | 1 |
Pouchain, D | 1 |
Vaillant Roussel, H | 1 |
Perault-Pochat, MC | 1 |
Jaafari, N | 1 |
Boussageon, R | 1 |
Ferber-Viart, C | 1 |
Dubreuil, C | 1 |
Vidal, PP | 2 |
LEAU, O | 2 |
DUCROT, R | 2 |
CELICE, J | 1 |
DUCHESNAY, G | 1 |
Vibert, N | 1 |
1 review available for acetyl-dl-leucine and Vertigo
Article | Year |
---|---|
Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials.
Topics: Dizziness; Humans; Leucine; Randomized Controlled Trials as Topic; Vertigo | 2019 |
1 trial available for acetyl-dl-leucine and Vertigo
Article | Year |
---|---|
Effects of acetyl-DL-leucine in vestibular patients: a clinical study following neurotomy and labyrinthectomy.
Topics: Adult; Aged; Combined Modality Therapy; Ear, Inner; Female; Humans; Leucine; Male; Meniere Disease; | 2009 |
3 other studies available for acetyl-dl-leucine and Vertigo
Article | Year |
---|---|
[Action of acetylleucine on experimental vertigo in mice].
Topics: Animals; Leucine; Mice; Vertigo | 1957 |
[Trial therapy of labyrinthine vertigo by acetyl-DL-leucine].
Topics: Humans; Leucine; Meniere Disease; Vertigo | 1958 |
In vitro effects of acetyl-DL-leucine (tanganil) on central vestibular neurons and vestibulo-ocular networks of the guinea-pig.
Topics: Abducens Nerve; Animals; Brain; Drug Resistance; Ear, Inner; Evoked Potentials; Female; Guinea Pigs; | 2001 |